DUBLIN (AP) — DUBLIN (AP) — Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $1.2 million in its fourth quarter.
On a per-share basis, the Dublin-based company said it had a loss of less than 1 cent. Earnings, adjusted for restructuring costs and stock option expense, were 1 cent per share.
The biopharmaceutical company posted revenue of $49.2 million in the period.
For the year, the company reported that its loss narrowed to $38.8 million, or 9 cents per share. Revenue was reported as $213.6 million.
Amarin shares have risen 11% since the beginning of the year. The stock has risen 35% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
